carnosine has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezhnoy, DS; Fedorova, TN; Kulikova, OI; Lopachev, AV; Orlova, VS; Stvolinsky, SL | 1 |
| Afshin-Majd, S; Baluchnejadmojarad, T; Khalili, M; Mehranmehr, N; Roghani, M | 1 |
2 other study(ies) available for carnosine and Parkinsonian Disorders
| Article | Year |
|---|---|
Neuroprotective effect of the carnosine - α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Brain; Carnosine; Dopamine; Homovanillic Acid; Male; Micelles; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Rats, Wistar; Serotonin; Thioctic Acid | 2018 |
Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.
Topics: Animals; Carnosine; Male; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Treatment Outcome | 2015 |